JP2024500354A5 - - Google Patents
Info
- Publication number
- JP2024500354A5 JP2024500354A5 JP2023535392A JP2023535392A JP2024500354A5 JP 2024500354 A5 JP2024500354 A5 JP 2024500354A5 JP 2023535392 A JP2023535392 A JP 2023535392A JP 2023535392 A JP2023535392 A JP 2023535392A JP 2024500354 A5 JP2024500354 A5 JP 2024500354A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- amino acid
- item
- terminus
- domains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063123915P | 2020-12-10 | 2020-12-10 | |
| US63/123,915 | 2020-12-10 | ||
| PCT/US2021/062951 WO2022125986A1 (en) | 2020-12-10 | 2021-12-10 | Orthogonal mutations for heterodimerization |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500354A JP2024500354A (ja) | 2024-01-09 |
| JP2024500354A5 true JP2024500354A5 (cg-RX-API-DMAC7.html) | 2024-05-30 |
Family
ID=81974005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535392A Pending JP2024500354A (ja) | 2020-12-10 | 2021-12-10 | ヘテロ二量体化のための直交変異 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12312418B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4259194A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024500354A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230118612A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116867514A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021397322A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3207821A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL303518A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023006899A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022125986A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023245021A2 (en) * | 2022-06-14 | 2023-12-21 | Invenra Inc. | Multispecific binding agents that target cd25 and/or ctla4 and uses thereof |
| WO2025129132A1 (en) * | 2023-12-14 | 2025-06-19 | Invenra Inc. | Multispecific binding agents that target ctla4 and/or cd25 and uses thereof |
| WO2025151752A1 (en) | 2024-01-10 | 2025-07-17 | Xilio Development, Inc. | Masked il-2 cytokines and methods of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013537416A (ja) * | 2010-08-13 | 2013-10-03 | メディミューン リミテッド | 変異型Fc領域を含むモノマーポリペプチド及び使用方法 |
| CN103429620B (zh) * | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| EA032681B1 (ru) * | 2012-11-27 | 2019-07-31 | Аджоу Юниверсити Индастри-Академик Кооперейшн Фаундейшн | ГЕТЕРОДИМЕР Fc ИММУНОГЛОБУЛИНА, СОДЕРЖАЩИЙ ВАРИАНТ ДОМЕНА CH3 ДЛЯ ОБРАЗОВАНИЯ АНТИТЕЛА ИЛИ ГИБРИДНОГО БЕЛКА С ГЕТЕРОМЕРНЫМ Fc С ВЫСОКОЙ ЭФФЕКТИВНОСТЬЮ, СПОСОБ ДЛЯ ЕГО ПОЛУЧЕНИЯ И ИСПОЛЬЗОВАНИЯ |
| SG11201506451UA (en) * | 2013-03-06 | 2015-09-29 | Merrimack Pharmaceuticals Inc | Anti-c-met tandem fc bispecific antibodies |
| JP6724023B2 (ja) * | 2015-02-09 | 2020-07-15 | リサーチ ディベロップメント ファウンデーション | 改善された補体活性化を示す操作された免疫グロブリンfcポリペプチド |
| EP3511340B1 (en) * | 2016-08-10 | 2024-10-02 | Ajou University Industry-Academic Cooperation Foundation | Heterodimeric fc-fused cytokine and pharmaceutical composition comprising the same |
| DK3529269T3 (da) * | 2016-10-19 | 2026-02-23 | Invenra Inc | Antistof-konstruktioner |
| US20200095327A1 (en) * | 2017-02-08 | 2020-03-26 | Dragonfly Therapeutics, Inc. | Antibody heavy chain variable domains targeting the nkg2d receptor |
| IL274071B2 (en) * | 2017-10-30 | 2025-10-01 | Hoffmann La Roche | Method for generating in vivo multispecific antibodies from monospecific antibodies |
| WO2019204522A1 (en) * | 2018-04-17 | 2019-10-24 | Invenra Inc. | Binding molecules |
| PE20210320A1 (es) * | 2018-06-01 | 2021-02-16 | Novartis Ag | Moleculas de union contra bcma y usos de las mismas |
| JP7812230B2 (ja) * | 2019-04-25 | 2026-02-09 | エフ. ホフマン-ラ ロシュ アーゲー | ポリペプチド鎖交換による抗体由来ポリペプチドの生成 |
| MX2022010176A (es) * | 2020-02-20 | 2023-01-16 | Win Therapeutics Inc | Moléculas de unión biespecíficas a gd2 y b7h2 y métodos de uso. |
-
2021
- 2021-12-10 MX MX2023006899A patent/MX2023006899A/es unknown
- 2021-12-10 AU AU2021397322A patent/AU2021397322A1/en active Pending
- 2021-12-10 JP JP2023535392A patent/JP2024500354A/ja active Pending
- 2021-12-10 IL IL303518A patent/IL303518A/en unknown
- 2021-12-10 WO PCT/US2021/062951 patent/WO2022125986A1/en not_active Ceased
- 2021-12-10 CN CN202180091688.7A patent/CN116867514A/zh active Pending
- 2021-12-10 US US17/548,375 patent/US12312418B2/en active Active
- 2021-12-10 KR KR1020237022864A patent/KR20230118612A/ko active Pending
- 2021-12-10 CA CA3207821A patent/CA3207821A1/en active Pending
- 2021-12-10 EP EP21904522.6A patent/EP4259194A4/en active Pending
-
2025
- 2025-04-25 US US19/190,527 patent/US20260078202A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230068801A1 (en) | Multispecific antibodies | |
| CN107207592B (zh) | 结构域交换的抗体 | |
| IL274071B1 (en) | Method for in vivo generation of multispecific antibodies from monospecific antibodies | |
| JP2021521781A5 (cg-RX-API-DMAC7.html) | ||
| JP2019533441A5 (cg-RX-API-DMAC7.html) | ||
| JP2021533779A5 (cg-RX-API-DMAC7.html) | ||
| AU2017359813B2 (en) | Anti-PD-1/anti-HER2 natural antibody structure-like bispecific antibody of heterodimeric form and preparation thereof | |
| JP2021522162A5 (cg-RX-API-DMAC7.html) | ||
| HRP20241775T1 (hr) | Bispecifična protutijela koja se specifično vežu na pd1 i lag3 | |
| CN111699201B (zh) | 抗pd-1/抗her2天然抗体结构的异源二聚双特异性抗体及其制备方法 | |
| RU2015145719A (ru) | Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения | |
| JP2019536734A5 (cg-RX-API-DMAC7.html) | ||
| US20260078202A1 (en) | Orthogonal mutations for heterodimerization | |
| KR20210042326A (ko) | 조작된 Fc-항원 결합 도메인 작제물에 관련된 조성물 및 방법 | |
| BR112021000416A2 (pt) | Composições e métodos relacionados a construtos do domínio de ligação fc-antígeno manipulado direcionado a cd38 | |
| JP2023501276A5 (cg-RX-API-DMAC7.html) | ||
| BR112021000383A2 (pt) | Composições e métodos relacionados a construtos do domínio de ligação fc-antígeno manipulado direcionado a pd-l1 | |
| BR112021000393A2 (pt) | Composições e métodos relacionados a construtos do domínio de ligação fc-antígeno manipulado | |
| KR20210043583A (ko) | 조작된 Fc-항원 결합 도메인 작제물에 관련된 조성물 및 방법 | |
| RU2023135060A (ru) | Антитела, связывающиеся с cd3 | |
| JP2022028645A5 (cg-RX-API-DMAC7.html) | ||
| RU2025130619A (ru) | Биспецифические агонистические антитела к рецептору i типа, подобному рецептору активина а (alk1) | |
| TH2101006347A (th) | โปรตีนการจับชนิดไตรสเปซิฟิกและ/หรือไตรวาเลนต์ที่ใช้รูปแบบโดเมนแปรผันได้คู่ แบบไขว้ (codv) สำหรับการบำบัดการติดเชื้อ hiv | |
| NZ772085B2 (en) | Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123 | |
| NZ772085A (en) | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123 |